Format

Send to

Choose Destination
Br J Oral Maxillofac Surg. 2015 Nov;53(9):826-30. doi: 10.1016/j.bjoms.2015.06.022. Epub 2015 Jul 16.

Effectiveness of 0.2% chlorhexidine gel and a eugenol-based paste on postoperative alveolar osteitis in patients having third molars extracted: a randomised controlled clinical trial.

Author information

1
Saveetha Dental College, Department Oral & Maxillofacial Surgery, 162 Poonammallee High Road, Chennai 600077, India. Electronic address: jamesjesudasan@yahoo.co.in.
2
Saveetha Dental College, Department Oral & Maxillofacial Surgery, 162 Poonammallee High Road, Chennai 600077, India. Electronic address: docwahab@hotmail.com.
3
Saveetha Dental College, Department Oral & Maxillofacial Surgery, 162 Poonammallee High Road, Chennai 600077, India. Electronic address: mrmsekar@yahoo.com.

Abstract

The aim of this study was to compare the effect of application of 0.2% chlorhexidine gel, a eugenol-based paste, together with a control group on the postoperative incidence of alveolar osteitis in patients having third molars extracted. A total of 270 patients who had this procedure at the Dept of Oral and Maxillofacial Surgery, Saveetha Dental College and who met the inclusion criteria were enrolled in the study and divided into 3 groups: the first had a 0.2% chlorhexidine-based gel applied to the alveolar socket once after extraction; the second had a eugenol-based paste applied to the alveolar socket once after extraction; and the third group acted as controls, with no treatment. The incidence of alveolar osteitis was recorded for 7 days. We also recorded postoperative pain, inflammation, infection, and wound healing. Nine of the control group (10%) and 2 (2%) of the chlorhexidine group developed alveolar osteitis on the seventh postoperative day. The overall incidence (11/270) was 4%, which is less than reported elsewhere. The distribution of alveolar osteitis among the 3 groups was significant (p=0.002), with the eugenol group having no cases. The chlorhexidine group showed less incidence of alveolar osteitis than other reported studies and also less pain, inflammation, infection, and better wound healing than the control group. We conclude that eugenol was the better of the 2 interventions.

KEYWORDS:

Alveolar osteitis; Dry socket; Intra-alveolar medication; Prevention of alveolar osteitis

PMID:
26188932
DOI:
10.1016/j.bjoms.2015.06.022
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center